L-Lysine Clonixinate

• CAT Number: R049678
• CAS Number: 55837-30-4
• Molecular Formula: C19H25ClN4O4
• Molecular Weight: 408.88
• Purity: ≥95%
• Synonyms: L-Lysine 2-[(3-Chloro-2-methylphenyl)amino]-3-pyridinecarboxylate; L-Lysine Mono[2-[(3-chloro-2-methylphenyl)amino]-3-pyridinecarboxylate]; Clonix; Clonixin lysinate; Clonixin Lysine Salt; Deltar; Dolagial; Dorixina; L 104; Lysine Clonixinate
• Storage: Desiccate at -80C
• IUPAC Name: 2-(3-chloro-2-methylanilino)pyridine-3-carboxylic acid;(2S)-2,6-diaminohexanoic acid
• InChI: InChI=1S/C13H11ClN2O2.C6H14N2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12;7-4-2-1-3-5(8)6(9)10/h2-7H,1H3,(H,15,16)(H,17,18);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1
• InChIKey: CVNFYQCHAWFYQI-ZSCHJXSPSA-N
• SMILES: CC1=C(C=CC=C1Cl)NC2=C(C=CC=N2)C(=O)O.C(CCN)C[C@@H](C(=O)O)N

L-Lysine clonixinate（Cat No.:R049678）is a non-steroidal anti-inflammatory drug (NSAID) derived from nicotinic acid and the amino acid L-lysine. It is commonly used for its analgesic and anti-inflammatory properties, particularly in the treatment of pain associated with musculoskeletal disorders, dysmenorrhea, and dental procedures. Unlike traditional NSAIDs, L-lysine clonixinate is known for causing fewer gastrointestinal side effects due to its improved solubility and gastric tolerance. It works by inhibiting prostaglandin synthesis, thereby reducing inflammation and pain. The compound is typically administered orally or via injection for rapid therapeutic effect.